Regeneron Pharmaceuticals Inc. sell dimontalban
Start price
20.04.20
/
50%
€528.00
Target price
23.08.20
€290.00
Performance (%)
-1.52%
End price
23.08.20
€520.00
Summary
This prediction ended on 23.08.20 with a price of €520.00. With a performance of -1.52%, the SELL prediction by dimontalban was trending in the right direction. dimontalban has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -1.669% | -1.669% | 2.531% | -7.703% |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
Comments by dimontalban for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Sell mit Kursziel 290,0